AstraZeneca has been driving cardiovascular innovation for more than 100 years. Our enduring goal is to push the boundaries of science to further reduce cardiovascular morbidity and mortality beyond current treatments, and to deliver transformative cardiovascular medicines to the people who need them Our bold ambition is to stop, reverse and cure CVRM diseases by maximising our medicines, delivering innovative solutions, and advancing our pipeline. We are fundamentally transforming CVRM care. From prevention to treatment to improved survival, we empower patients with cardiovascular and metabolic diseases to do more.